Namilumab (CSF2/GM-CSF) - Research Grade Biosimilar
Product Specifications
Background
Namilumab has been used in trials studying the treatment of Plaque Psoriasis and Rheumatoid Arthritis.
Immunogen
Homo sapiens / CSF2/GM-CSF [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Neuroscience
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Fragment
IgG1-kappa
NCBI Organism
Homo sapiens
Other Product Names
MT203
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRV-0042533-01 20 µL
Monoclonal Antibody to Rh Blood Group, D Antigen (RHD)
Sign In for Pricing
View Details TRV-0042533-02 100 µL
Monoclonal Antibody to Rh Blood Group, D Antigen (RHD)
Sign In for Pricing
View Details TRV-0042533-03 200 µL
Monoclonal Antibody to Rh Blood Group, D Antigen (RHD)
Sign In for Pricing
View Details TRV-0042533-04 1 mL
Monoclonal Antibody to Rh Blood Group, D Antigen (RHD)
Sign In for Pricing
View Details 